Find similar content

Source channel @githubtrending · Post #14896 · Jul 2

#python#ai#authentication#authorization#claude#cursor#fastapi#llm#mcp#mcp_server#mcp_servers#modelcontextprotocol#openapi#windsurf FastAPI-MCP is a tool that lets you easily turn your FastAPI web API endpoints into Model Context Protocol (MCP) tools, which AI agents can use directly. It requires almost no setup—just connect it to your FastAPI app, and it automatically preserves your request/response data models and documentation. It also includes built-in authentication using your existing FastAPI security methods. You can run the MCP server inside your app or separately, and it communicates efficiently using FastAPI’s ASGI interface. This makes it simple to integrate AI capabilities with your existing FastAPI services without rewriting code, saving you time and effort while keeping your API secure and well-documented[1][5]. https://github.com/tadata-org/fastapi_mcp

Hashtags

#python #ai #authentication #authorization #claude #cursor #fastapi #llm #mcp #mcp_server #mcp_servers #modelcontextprotocol #openapi #windsurf

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment